Mohamed Sharaf
8PUBLICATIONS
44CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Jan 23, 2026
Guselkumab Improves Patient-Reported Outcomes Among Participants with Psoriatic Arthritis and Inadequate Response to Tumor Necrosis Factor Inhibitors in the COSMOS Study.Laure Gossec, Xenofon Baraliakos, James Galloway
|Dec 15, 2025
Influence of Biological Sex on Participant Characteristics, Guselkumab Efficacy and Radiographic Progression in Active Psoriatic Arthritis: Post Hoc Analysis of Three Randomized Trials.Dafna D Gladman, Lihi Eder, Carlo Selmi
|Sep 19, 2025
Impact of dactylitis and enthesitis resolution on disease control in guselkumab-treated psoriatic arthritis patients with TNFi-IR: COSMOS post hoc analysis.Helena Marzo-Ortega, Iain B McInnes, Mohamed Sharaf
|Jul 21, 2025
Guselkumab Efficacy in Biologic-Naïve Participants with Psoriatic Arthritis and Severe Disease Activity: Post Hoc Analysis of a Phase 3 Study.Christopher T Ritchlin, Ennio Lubrano, Maria Sole Chimenti
|Dec 13, 2024
Sustained response to guselkumab regardless of baseline characteristics in patients with active psoriatic arthritis and inadequate response to TNF inhibitors: results from the phase 3b COSMOS clinical trial.Iain B McInnes, Philipp Sewerin, Mohamed Sharaf
|Oct 22, 2024
Multi-domain effectiveness of guselkumab evaluated via composite indices through 1 year in patients with PsA and inadequate response to TNFi: post hoc analysis of COSMOS.Laure Gossec, Xenofon Baraliakos, Daniel Aletaha
Pageof 2
Frequent Collaborators
6 joint publications
Frederic Lavie
4 joint publications
Laura C Coates
4 joint publications
Emmanouil Rampakakis
3 joint publications
Iain B McInnes
3 joint publications
Atul Deodhar
3 joint publications
Philip Mease
2 joint publications
Carlo Selmi
2 joint publications
Georg Schett
2 joint publications
Xenofon Baraliakos
2 joint publications
Laure Gossec
